Xarostat Gold 10 Capsule is a combination pharmaceutical formulation containing Aspirin (75mg), Rosuvastatin (10mg), and Clopidogrel (75mg), designed for the management and prevention of cardiovascular diseases. Aspirin, an antiplatelet agent, inhibits cyclooxygenase enzymes, thereby reducing thromboxane A2 synthesis and preventing platelet aggregation. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C), contributing to the prevention of atherosclerotic plaque formation. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, further reducing platelet activation and aggregation. The combined action of these agents provides synergistic benefits in reducing the risk of myocardial infarction, stroke, and other thrombotic cardiovascular events, particularly in patients with established coronary artery disease or those at high risk. Xarostat Gold 10 Capsule should be administered under medical supervision, with careful monitoring for potential adverse effects such as bleeding, hepatic dysfunction, or hypersensitivity reactions. It is contraindicated in patients with active bleeding disorders, severe hepatic impairment, or known hypersensitivity to any component. This combination therapy offers a comprehensive approach to cardiovascular risk management by targeting multiple pathophysiological mechanisms.